Home › Breast Cancer › Kansas
Breast Cancer clinical trials in Kansas
26 studies for Breast Cancer are looking for participants at sites in Kansas.
Cities in Kansas
- Kansas City12 studies
- Overland Park10 studies
- Topeka6 studies
- Wichita5 studies
- Hays4 studies
- Salina4 studies
- Olathe4 studies
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- and 4 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- The University of Kansas Cancer Center, Westwood
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT06377852A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Cancer Center of Kansas, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06492616Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Kansas Hospital-Cancer Center, Fairway
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07287917Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- University of Kansas Cancer Center, Westwood
- Cancer Center of Kansas, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06982521Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- HaysMed, Hays
- and 10 more
RecruitingPhase 3
Ages 18 to 60 · Women · Updated Sep 2, 2026 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- AMR Kansas City Oncology, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
- Hays Medical Center Dreiling-Schmidt Cancer Institute, Hays
- KCCC West, Kansas City
- KCCC Overland Park, Overland Park
- and 3 more
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 18, 2026 · NCT02302742Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06500481Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
- University of Kansas Medical Center, Fairway
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06263543Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- University of Kansas Cancer Center, Kansas City
RecruitingPhase 2Healthy volunteers welcome
Ages 45 to 74 · Women · Updated Aug 4, 2026 · NCT06195306Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Kansas Medical Center (KUMC), Westwood
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366E-Mindfulness Approaches for Living After Breast Cancer
- Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka
RecruitingPhase 3
Ages 18 to 50 · All sexes · Updated Aug 4, 2026 · NCT06748222Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- University of Kansas Cancer Center, Kansas City
RecruitingPhase 2
Ages 18 to 55 · Women · Updated Jul 27, 2026 · NCT06184750HER2-positive Breast Cancer Registry
- The University of Kansas Cancer Center, Westwood
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 17, 2026 · NCT06603597Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- University of Kansas Cancer Center, Kansas City
RecruitingPhase 2
Ages 35 and older · Women · Updated Jul 7, 2026 · NCT05941520Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- The University of Kansas Cancer Center, Westwood
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06757634Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
- The University of Kansas Cancer Center (KUCC), Fairway
- The University of Kansas Cancer Center - Westwood, Kansas City
- KUCC - Indian Creek, Overland Park
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07220135De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- University of Kansas Cancer Center, Kansas City
- The University of Kansas Cancer Center - Olathe, Olathe
- University of Kansas Cancer Center-Overland Park, Overland Park
- and 8 more
RecruitingPhase 3
Ages 50 to 70 · All sexes · Updated Apr 23, 2026 · NCT04852887Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
- The University of Kansas Cancer Center, Westwood
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT06374459Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- and 6 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT06418204EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- University of Kansas Cancer Center, Westwood
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06401421Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
- Cancer Center of Kansas, Wichita
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT04553770High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
- University of Kansas Medical Center, Kansas City
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 65 · Women · Updated Oct 29, 2025 · NCT00291096S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- HaysMed University of Kansas Health System, Hays
- University of Kansas Cancer Center-West, Kansas City
- University of Kansas Cancer Center, Kansas City
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.